Search results
Axsome (AXSM) Stock Falls Despite Q4 Earnings & Revenue Beat
Zacks via Yahoo Finance· 3 months agoAxsome Therapeutics, Inc. AXSM reported an adjusted loss of 73 cents per share for the fourth...
Axsome (AXSM) Begins Dosing in Depression Study on Sunosi
Zacks via Yahoo Finance· 2 months agoAxsome (AXSM) doses the first patient in the phase III PARADIGM study evaluating Sunosi...
Relmada Tanks After 'Paradoxical Results' Undermine Depression Drug; Axsome Surges
Investor's Business Daily· 2 years agoRelmada Therapeutics stock crashed Thursday after its depression treatment failed a final-phase...
Axsome (AXSM) Soars on FDA Nod for Depression Drug, Auvelity
Zacks via Yahoo Finance· 2 years agoThe FDA approves Axsome's (AXSM) Auvelity extended-release tablets for the treatment of major...
Biotech Stock Roundup: GILD, BLUE, AXSM's Drug Approvals, FHTX Study Update & More
Zacks via Yahoo Finance· 2 years agoDrug approvals and other regulatory updates are in focus in the biotech sector. COVID-19 vaccine...
Axsome Wins A 60-Year First In Depression; And Shares Catapult 40%
Investor's Business Daily· 2 years agoThe Food and Drug Administration approved a new depression treatment from Axsome Therapeutics,...
Teva Plots Its Knockoff Of Axsome's New Depression Drug, Sending The Biotech Sprawling
Investor's Business Daily· 1 year agoTeva Pharmaceutical said Monday it plans a competing knockoff of Axsome Therapeutics' new depression...
Axsome Therapeutics Expects Up To $11.5 Billion In Peak Sales, Wallops Analysts' Forecasts
Investor's Business Daily· 12 months agoAxsome Therapeutics expects its eight products to generate up to $11.5 billion in peak U.S. sales,...
11 Oversold NASDAQ Stocks To Buy Right Now
Insider Monkey via Yahoo Finance· 3 months agoIn this article, we will be taking a look at 11 oversold NASDAQ stocks to buy right now. To skip our detailed analysis of current stock market news, you...
Axsome Therapeutics Just Took Its Key Moving Averages — Here's Why
Investor's Business Daily· 2 years agoThe Food and Drug Administration could be nearing a decision on Axsome Therapeutics' depression...
